Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 7/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL296878 | 0.86 | TSHR (0.39) | TSHRTDP1 | |
| Alcohol SCHEMBL18544095 | 0.86 | TSHR (0.46) | ALDH1A1TSHRLMNATDP1 | |
| Alcohol SCHEMBL168419 | 0.86 | TSHR (0.46) | ALDH1A1TSHRLMNATDP1 | |
| Butyl Alcohol SCHEMBL1078212 | 0.85 | ALDH1A1 (0.61) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| Butyl Alcohol SCHEMBL23751337 | 0.83 | ALDH1A1 (0.58) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| Alcohol SCHEMBL2888838 | 0.83 | TSHR (0.43) | ALDH1A1TSHRLMNATDP1 | |
| Hexane SCHEMBL27772646 | 0.81 | SMN1; SMN2 (0.45) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| 1-Hexanol SCHEMBL28202584 | 0.81 | LMNA (0.65) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| Isopropyl Alcohol SCHEMBL6672907 | 0.80 | TSHR (0.40) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| Ethylene Glycol SCHEMBL1862814 | 0.80 | TSHR (0.33) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080044861-A1 | Methods for Recovering Isoflavones from Fermentation Processes | FERMALOGIC, INC. (US) | 2008-02-21 | — | — | US | claimed |
| WO-2008021699-A2 | METHODS FOR RECOVERING ISOFLAVONES FROM FERMENTATION PROCESSES | FERMALOGIC, INC. (US) | 2008-02-21 | — | — | WO | claimed |
| CN-116120301-A | Mesylate crystal form of compound, pharmaceutical composition and application | 深圳开悦生命科技有限公司 | 2023-05-16 | — | — | CN | disclosed |
| US-10907091-B2 | Organic compound and electrochromic element | CANON KABUSHIKI KAISHA (JP) | 2021-02-02 | — | — | US | disclosed |
| EP-3521398-B1 | ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT | CANON KK (JP) | 2020-11-18 | — | — | EP | disclosed |
| US-20190241798-A1 | ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2019-08-08 | — | — | US | disclosed |
| EP-3521398-A1 | ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2019-08-07 | — | — | EP | disclosed |
| US-7547716-B2 | Sulfonamide derivatives | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2009-06-16 | — | — | US | disclosed |
| US-20080044861-A1 | Methods for Recovering Isoflavones from Fermentation Processes | FERMALOGIC, INC. (US) | 2008-02-21 | — | — | US | disclosed |
| WO-2008021699-A2 | METHODS FOR RECOVERING ISOFLAVONES FROM FERMENTATION PROCESSES | FERMALOGIC, INC. (US) | 2008-02-21 | — | — | WO | disclosed |
| EP-1402890-B1 | SULFONAMIDE DERIVATIVES | INST MED MOLECULAR DESIGN INC (JP) | 2008-01-09 | — | — | EP | disclosed |
| EP-1402890-A1 | SULFONAMIDE DERIVATIVES | Institute of Medicinal Molecular Design, Inc. (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-5635513-A | ANTAGONIST OF 5-HYDROXYTRYPTAMINE; ANTINAUSEA AND VOMITING | GLAXO GROUP LIMITED (GB) | 1997-06-03 | — | — | US | disclosed |
| EP-0652877-A1 | METHANESULPHONATE | GLAXO GROUP LIMITED (GB) | 1995-05-17 | — | — | EP | disclosed |
| WO-1994003452-A1 | METHANESULPHONATE | GLAXO GROUP LIMITED (GB) | 1994-02-17 | — | — | WO | disclosed |
| EP-0581388-A1 | Pyridoindolone Methansulphonate as 5HT and 5HT3 receptor antagonists | GLAXO GROUP LIMITED (GB) | 1994-02-02 | — | — | EP | disclosed |
| EP-0275997-B1 | 3(2H)PYRIDAZINONE, PROCESS FOR ITS PREPARATION AND ANTAGONISTIC AGENT AGAINST SRS-A CONTAINING IT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-4978665-A | ANTIALLERGENS | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1990-12-18 | — | — | US | disclosed |
| EP-0275997-A1 | 3(2H)pyridazinone, process for its preparation and antagonistic agent against SRS-A containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1988-07-27 | — | — | EP | disclosed |
| US-4379154-A | Thiocarboxamide derivatives and their use as pharmaceuticals | RHONE-POULENC SANTE (FR) | 1983-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10907091-B2 | Organic compound and electrochromic element | H1-2, H1-0, H1-10 | ALDH1A1 1174/4885TSHR 2779/4885SMN1; SMN2 2560/4885 |
| US-20190241798-A1 | ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT | H1-2, H1-0, H1-10 | ALDH1A1 1174/4885TSHR 2779/4885SMN1; SMN2 2560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.